1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, January 2017 (p30)

Therapy Analysis & Statistics, January 2017 (p30)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

871-900 of about 8200 reports

Purchase Reports From Reputable Market Research Publishers

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2017

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Therapy
 Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2017

Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Therapy
HIV Protease Inhibitors -Pipeline Insights, 2017

HIV Protease Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “HIV Protease Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the HIV Protease Inhibitors. The ...

  • Industries : Therapy
 Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017

Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy ...

  • Industries : Mental Health, Therapy, Pathology, Oncology
Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2017

Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Therapy
 Contraceptives-Pipeline Insights, 2017

Contraceptives-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Contraceptives-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Contraceptives. The DelveInsight’sReport ...

  • Industries : Therapy
Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2017

Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Cannabinoid Receptor Type 1 (CB1) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid ...

  • Industries : Therapy
Src Tyrosine Kinase Inhibitors -Pipeline Insights, 2017

Src Tyrosine Kinase Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Src Tyrosine Kinase Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Src Tyrosine Kinase ...

  • Industries : Therapy
Beta Selective Thyroid Hormone Receptor Agonists -Pipeline Insights, 2017

Beta Selective Thyroid Hormone Receptor Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Beta Selective Thyroid Hormone Receptor Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Beta ...

  • Industries : Therapy
MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2017

MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “MT-2 Melatonin Receptor Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the MT-2 Melatonin Recepto ...

  • Industries : Therapy
Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2017

Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Estrogen Receptor Beta Partial Agonist-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Estrogen Recepto ...

  • Industries : Therapy
Aldosterone Antagonists -Pipeline Insights, 2017

Aldosterone Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Aldosterone Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Aldosterone Antagonists. The ...

  • Industries : Therapy
 Opium (Opioid) Addiction-Pipeline Insights, 2017

Opium (Opioid) Addiction-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Opium (Opioid) Addiction-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Opium (Opioid) Addiction. ...

  • Industries : Therapy
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2017

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Therapy
Melatonin Receptor Agonists -Pipeline Insights, 2017

Melatonin Receptor Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Melatonin Receptor Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Melatonin Receptor Agonists. ...

  • Industries : Therapy
Fusion Inhibitors -Pipeline Insights, 2017

Fusion Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fusion Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fusion Inhibitors. The DelveInsight’s ...

  • Industries : Therapy
Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2017

Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Therapy
Aurora B Kinase Inhibitors -Pipeline Insights, 2017

Aurora B Kinase Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Aurora B Kinase Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Aurora B Kinase Inhibitors. ...

  • Industries : Therapy
Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2017

Mineralocorticoid Receptor (MR) Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Mineralocorticoid Receptor (MR) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Mineralocorticoid ...

  • Industries : Therapy
L-Type Calcium Channel Blockers -Pipeline Insights, 2017

L-Type Calcium Channel Blockers -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “L-Type Calcium Channel Blockers-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the L-Type Calcium Channel ...

  • Industries : Therapy
Benzodiazepine Receptor Agonist -Pipeline Insights, 2017

Benzodiazepine Receptor Agonist -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Benzodiazepine Receptor Agonist-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Benzodiazepine Recepto ...

  • Industries : Therapy
Alpha Glucosidase Inhibitors -Pipeline Insights, 2017

Alpha Glucosidase Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Alpha Glucosidase Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Alpha Glucosidase Inhibitors. ...

  • Industries : Therapy
Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2017

Cannabinoid Receptor Type 1 (CB1) Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Cannabinoid Receptor Type 1 (CB1) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cannabinoid ...

  • Industries : Therapy
 Schizophrenia-API Insights, 2017

Schizophrenia-API Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuste ...

  • Industries : Therapy
  • Countries : United States
Adenosine A3 Receptor Antagonists -Pipeline Insights, 2017

Adenosine A3 Receptor Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Adenosine A3 Receptor Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A3 Recepto ...

  • Industries : Therapy
Glucocorticoid Receptor (GR) Antagonists -Pipeline Insights, 2017

Glucocorticoid Receptor (GR) Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Glucocorticoid Receptor (GR) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Glucocorticoid ...

  • Industries : Therapy
Somatostatin Receptor Agonist -Pipeline Insights, 2017

Somatostatin Receptor Agonist -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Somatostatin Receptor Agonist-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Somatostatin Recepto ...

  • Industries : Therapy
Adenosine A2 Receptor Antagonists -Pipeline Insights, 2017

Adenosine A2 Receptor Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Adenosine A2 Receptor Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A2 Recepto ...

  • Industries : Therapy
Adenosine A2A Receptor Agonists -Pipeline Insights, 2017

Adenosine A2A Receptor Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Adenosine A2A Receptor Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A2A Recepto ...

  • Industries : Therapy
Aurora Kinase Inhibitors -Pipeline Insights, 2017

Aurora Kinase Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Aurora Kinase Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Aurora Kinase Inhibitors. ...

  • Industries : Therapy

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.